Literature DB >> 20621587

Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.

Fabiana Canal1, María J Vicent, Gianfranco Pasut, Oddone Schiavon.   

Abstract

A series of PEG-epirubicin conjugates with different folic acid contents per polymer chain was synthesized in order to study the influence of polymer/targeting moiety ratio on selective cytotoxicity, cellular uptake and intracellular localization. Analogous carboxyl-terminated conjugates without folic acid were studied as control. The heterobifunctional HO-PEG-COOH was used as polymeric carrier, allowing the synthesis of conjugates with a good control over the chemical structure and the drug/polymer and polymer/targeting residue ratios. A dendron structure was synthesized at one end of the PEG chain with the aim to increase the number of folic acid molecules. L-2-aminoadipic acid was used as branching unit. The conjugates showed high stability under several physiological conditions. Biological evaluation was carried out in A549, HeLa and KB-3-1 human cell lines, as these cells have different levels of folate receptor (FR) expression. In particular A549 cells are FR negative (FR-), HeLa cells are FR positive (FR+) and KB-3-1 cells over-express FR (FR++). It was clearly shown that the biological activity of the conjugates was influenced by the presence and the number of folic acid molecules per polymer chain and by the level of FR expression on cell surface. Conjugates conformation in solution was also studied, as differences in size might well affect cell internalization. In the cell viability assay, conjugates without folic acid were unexpectedly more cytotoxic than the targeted conjugates, but their IC(50) values were similar in the three cell lines. Differently, the anti-proliferative activity of targeted derivatives markedly increased going from FR(-) to FR(++) cells. FACS and confocal microscopy studies showed greater cellular internalization with the targeted conjugates than with their non-targeted analogues; more importantly, this relationship is clearly dependent on folic acid content in the conjugates and FR expression level in the cell line used.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621587     DOI: 10.1016/j.jconrel.2010.05.027

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.

Authors:  Xiaobei Huang; Yanzhi Zhang; Guangfu Yin; Ximing Pu; Xiaoming Liao; Zhongbing Huang; Xianchun Chen; Yadong Yao
Journal:  J Mater Sci Mater Med       Date:  2015-02-04       Impact factor: 3.896

2.  Targeted drug delivery to tumors: myths, reality and possibility.

Authors:  You Han Bae; Kinam Park
Journal:  J Control Release       Date:  2011-06-06       Impact factor: 9.776

3.  Biodegradable Poly(ester-urethane) Carriers Exhibiting Controlled Release of Epirubicin.

Authors:  Karolina Żółtowska; Urszula Piotrowska; Ewa Oledzka; Marzena Kuras; Anna Zgadzaj; Marcin Sobczak
Journal:  Pharm Res       Date:  2017-01-24       Impact factor: 4.200

4.  FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.

Authors:  Jiyuan Yang; Rui Zhang; D Christopher Radford; Jindřich Kopeček
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

Review 5.  Nanotechnology-based approaches in anticancer research.

Authors:  Nasimudeen R Jabir; Shams Tabrez; Ghulam Md Ashraf; Shazi Shakil; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  Int J Nanomedicine       Date:  2012-08-09

6.  Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles.

Authors:  Jifu Hao; Tiantian Tong; Kai Jin; Qiannan Zhuang; Te Han; Yanping Bi; Jianzhu Wang; Xiaodan Wang
Journal:  Int J Nanomedicine       Date:  2017-03-24

7.  Ophiobolin A, a sesterpenoid fungal phytotoxin, displays different mechanisms of cell death in mammalian cells depending upon the cancer cell origin.

Authors:  Rachel Morrison; Tiffany Lodge; Antonio Evidente; Robert Kiss; Helen Townley
Journal:  Int J Oncol       Date:  2017-01-19       Impact factor: 5.650

Review 8.  Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer.

Authors:  Sibusiso Alven; Xhamla Nqoro; Buhle Buyana; Blessing A Aderibigbe
Journal:  Pharmaceutics       Date:  2020-04-29       Impact factor: 6.321

9.  Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy.

Authors:  Juan Chen; Xiaobing Yang; Liuqing Huang; Huixian Lai; Chuanhai Gan; Xuetao Luo
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.

Authors:  Anam Akhtar; Lucy Ghali; Scarlet Xiaoyan Wang; Celia Bell; Dong Li; Xuesong Wen
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.